4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011486
Chief Scientific Officer gave up 876 shares (to pay taxes)
- Chief Scientific Officer acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Scott · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-16 | Exercise or conversion : show line 1 in the form | +2,750 | 27,387 | D | ||
| 2019-02-19 | Shares withheld for taxes : show line 2 in the form | −876 | $58.03 | $50,834 | 26,511 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-16 | Exercise or conversion : show line 3 in the form Restricted stock units | −2,750 | 5,500 | D |
Loading xslF345X03/doc4.xml…